Back to Resource Hub Article

Making PRO Data Work in Oncology Trials

Patient-reported symptoms can reveal changes clinicians may not see between visits. But collecting PRO data alone isn't enough. The value comes from turning those data into timely action.

Originally published in Cancer Control, this perspective from Bill Byrom, PhD, and Anthony Everhart, MD, explores how electronic patient-reported outcomes (ePRO) can support remote symptom monitoring and timely clinical intervention in oncology. 

What you’ll learn 

  • Why clinician assessments may underestimate the frequency and severity of patient-reported symptoms
  • How frequent ePRO monitoring can help identify worsening symptoms earlier
  • How visualizations can surface symptom patterns and changes
  • How predefined alert thresholds can prompt timely clinical follow-up
  • What sponsors should consider when incorporating active symptom monitoring into oncology trial design 

Publication and authors 

Anthony Everhart, MD, Clinical Vice President, Internal Medicine, Signant Health  
Bill Byrom, PhD, Vice President, Product Intelligence & Positioning, Signant Health  

Read the full article:

Making PRO Data Work: Remote Monitoring, Real-Time Visualization,

and Timely Intervention in Oncology Trials and Patient Care

DOWNLOAD THE ARTICLE

What happens after patients report their symptoms?

Collecting patient-reported symptom data is only the beginning.

Signant's eCOA and clinical science experts help sponsors turn ePRO data into action with real-time visualizations, predefined alert thresholds, and workflows that enable earlier intervention.

Build monitoring into your trial from the start, so patient-reported symptoms can inform decisions when they matter.

Get notified on new marketing insights

Here mention the benefits of subscribing